Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swan, G. E.
Right arrow Articles by Carmelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swan, G. E.
Right arrow Articles by Carmelli, D.
Neurology 2000;54:2108-2114
© 2000 American Academy of Neurology


Articles

Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy

G. E. Swan, PhD, C. DeCarli, MD, B. L. Miller, MD, T. Reed, PhD, P. A. Wolf, MD and D. Carmelli, PhD

From the Center for Health Sciences (Drs. Swan and Carmelli), SRI International, Menlo Park, CA; the Department of Neurology (Dr. DeCarli), University of Kansas Medical Center, Kansas City; the University of California (Dr. Miller), San Francisco, CA; the Department of Medical & Molecular Genetics (Dr. Reed), Indiana University School of Medicine, Indianapolis; and the Boston University Medical Center (Dr. Wolf), MA.

Address correspondence and reprint requests to Dr. Gary E. Swan, Center for Health Sciences, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025.

OBJECTIVE: To characterize the risk factors and neuropsychological performance of two subgroups of community-dwelling, white elderly men free of severe cognitive impairment (n = 383; mean age, 72.9 ± 3.0 years) who differ on volumetric measurements of total brain parenchyma and white matter hyperintensity (WMH) volumes.

METHODS: Group comparisons were made of cerebrovascular disease risk factors measured at the time of imaging and at three prior examinations extending over 25 years of adult life. Measures of verbal memory and speed psychomotor processing at the time of imaging and 10 years before imaging were also available.

RESULTS: Compared with those in the "nonatrophy" group, individuals in the subgroup with "atrophy" (defined by low total brain volume and high WMH volume) were older, reported a higher level of depressive symptomatology, experienced a steeper decline in diastolic blood pressure (DBP) and a steeper increase in pulse pressure, were less physically active, had smoked for more years, and had a higher prevalence of several cardiovascular disease indicators, including an ankle/arm systolic blood pressure ratio less than 0.9, and hypertension. After multivariate analysis, the 25-year decline in DBP, the number of years smoked, and an ankle/arm index of less than 0.9 remained significant discriminators of the two groups. Lower levels of speeded performance at the time of imaging and a steeper 10-year decline in cognitive performance on selected tests were also observed in the atrophic group.

CONCLUSION: Community-dwelling older adults with volumetric brain measurements associated with accelerated aging are distinguishable on the basis of several health-related characteristics. These individuals also perform less well on certain tasks involving executive functioning.

Key words: MRI—Aging—White matter hyperintensities—Atrophy—Neuropsychological function.




This article has been cited by other articles:


Home page
HypertensionHome page
J. R. Jennings, M. F. Muldoon, E. M. Whyte, J. Scanlon, J. Price, and C. C. Meltzer
Brain Imaging Findings Predict Blood Pressure Response to Pharmacological Treatment
Hypertension, December 1, 2008; 52(6): 1113 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
C. A. Paul, R. Au, L. Fredman, J. M. Massaro, S. Seshadri, C. DeCarli, and P. A. Wolf
Association of Alcohol Consumption With Brain Volume in the Framingham Study
Arch Neurol, October 1, 2008; 65(10): 1363 - 1367.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. H. Swartz, D. T. Stuss, F. Gao, and S. E. Black
Independent Cognitive Effects of Atrophy and Diffuse Subcortical and Thalamico-Cortical Cerebrovascular Disease in Dementia
Stroke, March 1, 2008; 39(3): 822 - 830.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. F. Stewart, B. S. Schwartz, C. Davatzikos, D. Shen, D. Liu, X. Wu, A. C. Todd, W. Shi, S. Bassett, and D. Youssem
Past adult lead exposure is linked to neurodegeneration measured by brain MRI
Neurology, May 23, 2006; 66(10): 1476 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
C. Reitz, J. A. Luchsinger, M.-X. Tang, J. Manly, and R. Mayeux
Stroke and memory performance in elderly persons without dementia.
Arch Neurol, April 1, 2006; 63(4): 571 - 576.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Silvestrini, P. Pasqualetti, R. Baruffaldi, M. Bartolini, Y. Handouk, M. Matteis, F. Moffa, L. Provinciali, and F. Vernieri
Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease
Stroke, April 1, 2006; 37(4): 1010 - 1015.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
R. Au, J. M. Massaro, P. A. Wolf, M. E. Young, A. Beiser, S. Seshadri, R. B. D'Agostino, and C. DeCarli
Association of White Matter Hyperintensity Volume With Decreased Cognitive Functioning: The Framingham Heart Study
Arch Neurol, February 1, 2006; 63(2): 246 - 250.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
R. A. Mangiafico, F. Sarnataro, M. Mangiafico, and C. E. Fiore
Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels
Age Ageing, January 1, 2006; 35(1): 60 - 65.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
N. D. Prins, E. J. van Dijk, T. den Heijer, S. E. Vermeer, J. Jolles, P. J. Koudstaal, A. Hofman, and M. M. B. Breteler
Cerebral small-vessel disease and decline in information processing speed, executive function and memory
Brain, September 1, 2005; 128(9): 2034 - 2041.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Gustafson, L. Lissner, C. Bengtsson, C. Bjorkelund, and I. Skoog
A 24-year follow-up of body mass index and cerebral atrophy
Neurology, November 23, 2004; 63(10): 1876 - 1881.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. M. Wiseman, B. K. Saxby, E. J. Burton, R. Barber, G. A. Ford, and J. T. O'Brien
Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects
Neurology, November 23, 2004; 63(10): 1892 - 1897.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Seshadri, P. A. Wolf, A. Beiser, M. F. Elias, R. Au, C. S. Kase, R. B. D'Agostino, and C. DeCarli
Stroke risk profile, brain volume, and cognitive function: The Framingham Offspring Study
Neurology, November 9, 2004; 63(9): 1591 - 1599.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
J. Razani, K. Boone, I. Lesser, and D. Weiss
Effects of Cigarette Smoking History on Cognitive Functioning in Healthy Older Adults
Am J Geriatr Psychiatry, August 1, 2004; 12(4): 404 - 411.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. DeCarli, D. Mungas, D. Harvey, B. Reed, M. Weiner, H. Chui, and W. Jagust
Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia
Neurology, July 27, 2004; 63(2): 220 - 227.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. D. Atwood, P. A. Wolf, N. L. Heard-Costa, J. M. Massaro, A. Beiser, R. B. D'Agostino, and C. DeCarli
Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study
Stroke, July 1, 2004; 35(7): 1609 - 1613.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A A Capizzano, L Acion, T Bekinschtein, M Furman, H Gomila, A Martinez, R Mizrahi, and S E Starkstein
White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 822 - 827.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. F. Elias, L. M. Sullivan, R. B. D'Agostino, P. K. Elias, A. Beiser, R. Au, S. Seshadri, C. DeCarli, and P. A. Wolf
Framingham Stroke Risk Profile and Lowered Cognitive Performance
Stroke, February 1, 2004; 35(2): 404 - 409.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Y. Wong, T. H. Mosley Jr., R. Klein, B. E.K. Klein, A. R. Sharrett, D. J. Couper, and L. D. Hubbard
Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people
Neurology, September 23, 2003; 61(6): 806 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R J L Walters, N C Fox, J M Schott, W R Crum, J M Stevens, M N Rossor, and D J Thomas
Transient ischaemic attacks are associated with increased rates of global cerebral atrophy
J. Neurol. Neurosurg. Psychiatry, February 1, 2003; 74(2): 213 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
J. J. Campbell III and C. E. Coffey
Neuropsychiatric Significance of Subcortical Hyperintensity
J Neuropsychiatry Clin Neurosci, May 1, 2001; 13(2): 261 - 288.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.